跳至主要内容
临床试验/ISRCTN16448440
ISRCTN16448440进行中(未招募)未知

Effect of antenatal dietary Myo-inositol supplementation in women during pregnancy on the incidence of gestational diabetes mellitus (GDM) and fetal outcome: A randomized controlled trial

Sidra Medical and Research Center0 个研究点目标入组 640 人开始时间: 2021年5月26日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
入组人数
640

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • 1. All pregnant women booked for prenatal care at Sidra Medicine will be approached regardless of age, language spoken or place for delivery
  • 2. Gestational age less than 16 weeks
  • 3. Capacity to provide informed consent

排除标准

  • 1. Pre-gestational diabetes
  • 2. Booking fasting glucose of =5.1 mmol/l (92 mg/dl)
  • 3. Women on steroids during pregnancy
  • 4. Women using metformin for any other disorder e.g. PCOS
  • 5. Women taking Myo-inositol as part of any supplementation
  • 6. Cancer not in remission
  • 7. Women who lack the capacity to provide informed consent
  • 8. Women who had bariatric surgery
  • 9. Involvement in another interventional trial
  • 10. Polyhydramnios (this is a very unlikely finding before 16 weeks)

研究者

相似试验